Vicky Caveliers Selected Research

Vicky Caveliers Research Topics

Disease

28	Neoplasms (Cancer) 02/2022 - 09/2002
7	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2002
3	Inflammation (Inflammations) 09/2016 - 09/2003
3	Carcinoma (Carcinomatosis) 12/2014 - 05/2008
3	Heart Valve Diseases (Valvular Heart Disease) 09/2009 - 09/2007
3	Aortic Valve Insufficiency (Aortic Regurgitation) 06/2009 - 09/2007
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2003
2	Infarction (Infarctions) 12/2011 - 12/2007
2	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2009 - 09/2007
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2009 - 09/2007
2	Rhabdomyosarcoma 07/2007 - 09/2002
1	Atherosclerosis 01/2019
1	Atherosclerotic Plaque (Atheroma) 09/2016
1	Multiple Myeloma 12/2014
1	Chronic Renal Insufficiency 11/2013
1	Scorpion Stings 10/2012
1	Residual Neoplasm 03/2012
1	Brain Ischemia (Cerebral Ischemia) 12/2011
1	Stroke (Strokes) 12/2011
1	Hypoalbuminemia 02/2011
1	Memory Disorders (Memory Loss) 03/2010
1	Cognitive Dysfunction 03/2010
1	Necrosis 01/2010
1	Fibrosis (Cirrhosis) 01/2010
1	Heart Failure 12/2007
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 09/2007
1	Carcinoid Heart Disease 09/2007
1	Glioma (Gliomas) 07/2007

Drug/Important Bio-Agent (IBA)

15	Single-Domain AntibodiesIBA 02/2022 - 05/2008
5	Radioisotopes (Radionuclides)IBA 02/2022 - 03/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2008
4	human ERBB2 proteinIBA 01/2021 - 07/2011
3	Mannose ReceptorIBA 01/2021 - 08/2015
3	Pharmaceutical PreparationsIBA 11/2017 - 09/2007
3	Amino Acids FDA Link 09/2004 - 09/2002
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 09/2021 - 05/2013
2	LigandsIBA 06/2021 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 04/2016
2	AntigensIBA 07/2010 - 05/2010
2	Serotonin (5 Hydroxytryptamine)IBA 09/2009 - 09/2007
2	Pergolide (Permax)FDA Link 06/2009 - 09/2007
2	2-iodotyrosineIBA 07/2007 - 09/2004
2	Phenylalanine (L-Phenylalanine)FDA Link 07/2007 - 09/2002
1	Immune Checkpoint InhibitorsIBA 06/2021
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Astatine-211IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 11/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2016
1	CC ChemokinesIBA 08/2015
1	Tumor Biomarkers (Tumor Markers)IBA 05/2014
1	succinylated gelatinIBA 01/2014
1	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 11/2013
1	Scorpion Venoms (Scorpion Venom)IBA 10/2012
1	Antivenins (Antivenoms)IBA 10/2012
1	VenomsIBA 10/2012
1	Chelating AgentsIBA 03/2012
1	OximesIBA 12/2011
1	Endothelin-1 (Endothelin 1)IBA 12/2011
1	Firefly LuciferasesIBA 10/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2011
1	PolygelineIBA 03/2011
1	Lysine (L-Lysine)FDA Link 03/2011
1	AlbuminsIBA 02/2011
1	Blood Proteins (Serum Proteins)IBA 02/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011
1	Renilla LuciferasesIBA 02/2011
1	EnzymesIBA 07/2010
1	Proteins (Proteins, Gene)FDA Link 07/2010
1	Carcinoembryonic AntigenIBA 07/2010
1	ImmunosorbentsIBA 07/2010
1	valylvaline (Val-Val)IBA 03/2010
1	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 03/2010
1	TroponinIBA 01/2010
1	Serotonin AgentsIBA 09/2009
1	Cyproheptadine (Periactin)FDA Link 06/2009
1	Dihydrotachysterol (AT 10)IBA 04/2009
1	IndiumIBA 12/2007
1	Tyrosine (L-Tyrosine)FDA Link 07/2007
1	TurpentineIBA 09/2003
1	BenzamidesIBA 12/2002
1	sigma Receptors (sigma Receptor)IBA 12/2002
1	Human Serum Albumin FDA LinkGeneric 09/2002
1	Tryptophan (L-Tryptophan)FDA Link 09/2002
1	AsparagineIBA 09/2002
1	Proline (L-Proline)FDA Link 09/2002
1	Glutamic Acid (Glutamate)FDA Link 09/2002
1	Arginine (L-Arginine)FDA Link 09/2002

Therapy/Procedure

13	Therapeutics 02/2022 - 10/2011
3	Precision Medicine 01/2021 - 12/2014
2	Intravenous Injections 07/2011 - 09/2002
2	Injections 12/2007 - 12/2003
1	Radioimmunotherapy 03/2012
1	Catheters 12/2007
1	Intraperitoneal Injections 09/2002